Xconomy’s Digital Events →
Edward Lanphier is CEO of Sangamo Biosciences
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications